Evaluation of a New Potential Bevacizumab Biosimilar in Corneal Neovascularization
Objectives: To compare the antiangiogenic effects of bevacizumab and a new potential bevacizumab biosimilar (anti-human VEGF GU01) on suture-induced corneal neovascularization (CNV) in rabbits. Materials and Methods: CNV was induced in the right eyes of 15 rabbits by placing 7-0 black silk suture i...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Turkish Ophthalmology Society
2025-12-01
|
| Colección: | Türk Oftalmoloji Dergisi |
| Materias: | |
| Acceso en línea: | https://www.oftalmoloji.org/articles/evaluation-of-a-new-potential-bevacizumab-biosimilar-in-corneal-neovascularization/doi/tjo.galenos.2025.34783 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|